AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2021
Sep 18, 2021
32134_dirs_2021-09-17_1fa39b9d-1116-48f1-8661-2b03258d4663.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2021-09-16
Reporting Person: WHITFIELD ROY A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-16 | Common Stock | M | 40000 | $13.80 | Acquired | 225850 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-16 | Stock Option | $13.80 | M | 40000 | Disposed | 2021-09-18 | Common Stock (40000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 51500 | Indirect |
| Common Stock | 20000 | Indirect |
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20